<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="7250111S1198-743X(20)30293-7 doi: 10.1016/j.cmi.2020.05.016 : Systematic Review Clinical evidence for repurposing" exact="chloroquine" post="and hydroxychloroquine as antiviral agents: a systematic review RodrigoC.1FernandoS.D.2RajapakseS.3âˆ—[1)],"/>
 <result pre="10.1016/j.cmi.2020.05.016 : Systematic Review Clinical evidence for repurposing chloroquine and" exact="hydroxychloroquine" post="as antiviral agents: a systematic review RodrigoC.1FernandoS.D.2RajapakseS.3âˆ—[1)], [2)], [3)],"/>
 <result pre="as the COVID-19 resource centre remains active. Abstract Background Repurposing" exact="hydroxychloroquine" post="(HCQ) and chloroquine (CQ) as antiviral agents is a"/>
 <result pre="resource centre remains active. Abstract Background Repurposing hydroxychloroquine (HCQ) and" exact="chloroquine" post="(CQ) as antiviral agents is a re-emerging topic with"/>
 <result pre="or CQ is beneficial in COVID-19 infection. Keywords Antivirals Chikungunya" exact="Chloroquine" post="COVID-19 Dengue Hydroxychloroquine Pneumonia Editor: M. Paul Introduction With"/>
 <result pre="beneficial in COVID-19 infection. Keywords Antivirals Chikungunya Chloroquine COVID-19 Dengue" exact="Hydroxychloroquine" post="Pneumonia Editor: M. Paul Introduction With the advent of"/>
 <result pre="properties inÂ vitro or in animal studies is gaining popularity." exact="Chloroquine" post="(CQ), a well-established antimalarial agent, and hydroxychloroquine (HCQ), a"/>
 <result pre="is gaining popularity. Chloroquine (CQ), a well-established antimalarial agent, and" exact="hydroxychloroquine" post="(HCQ), a similarly established disease-modifying anti-rheumatic drug (DMARD), have"/>
 <result pre="800 mg/d for 16Â weeks (nÂ =Â 35) or 2)" exact="Zidovudine" post="500 mg/d for same duration (nÂ =Â 37) Significant"/>
 <result pre="decrease in viral load in both HCQ (p 0.02) and" exact="zidovudine" post="groups (p 0.001)No change in absolute CD4+ cell count"/>
 <result pre="copies/Î¼L and CD4+ cell countÂ &amp;gt;Â 150/Î¼L HCQ 200 mg/bid," exact="hydroxyurea" post="500 mg/bid and didanoside 125â€&quot;200 mg/bid according to bodyweight"/>
 <result pre="A,B or C; CDC immunological category 2 or 3 1)" exact="Zidovudine" post="(ZDV)+ didanosine (ddI) (nÂ =Â 25)2) ZDVÂ +Â ddIÂ"/>
 <result pre="C; CDC immunological category 2 or 3 1) Zidovudine (ZDV)+" exact="didanosine" post="(ddI) (nÂ =Â 25)2) ZDVÂ +Â ddIÂ +Â CQ"/>
 <result pre="1: pegylated interferon (IFN) 160 Î¼g subcutaneously weeklyÂ +Â oral" exact="ribavirin" post="1000â€&quot;1200 md/d for 12Â weeks (nÂ =Â 60)Group 2:"/>
 <result pre="with HCV (genotype 1) not responding to standard IFN and" exact="ribavirin" post="therapy CQ 150 mg (base)/d for 8Â weeks or"/>
 <result pre="effects due to recruiting control patients from a different institution," exact="azithromycin" post="administration in some patients only, and baseline age difference"/>
 <result pre="ROBINS-I tool. TableÂ 3 Clinical trials/studies in progression on using" exact="chloroquine" post="(CQ) or hydroxychloroquine (HCQ) as antiviral agents TableÂ 3"/>
 <result pre="3 Clinical trials/studies in progression on using chloroquine (CQ) or" exact="hydroxychloroquine" post="(HCQ) as antiviral agents TableÂ 3 Namea Reference ID"/>
 <result pre="Post-exposure prophylaxis for SARS-Coronavirus-2 NCT04308668 ClinicalTrials.gov Comparison of lopinavir/ritonavir or" exact="hydroxychloroquine" post="in patients with mild coronavirus disease (COVID-19) NCT04307693 ClinicalTrials.gov"/>
 <result pre="hydroxychloroquine in patients with mild coronavirus disease (COVID-19) NCT04307693 ClinicalTrials.gov" exact="Chloroquine" post="prevention of coronavirus disease (COVID-19) in the healthcare setting"/>
 <result pre="NCT04304053 ClinicalTrials.gov Various combination of protease inhibitors, oseltamivir, favipiravir, and" exact="chloroquine" post="for treatment of COVID19: a randomized control trial NCT04303299"/>
 <result pre="WHO ICTRP A prospective, open label, randomized, control trial for" exact="chloroquine" post="or hydroxychloroquine in patients with mild and common novel"/>
 <result pre="A prospective, open label, randomized, control trial for chloroquine or" exact="hydroxychloroquine" post="in patients with mild and common novel coronavirus pulmonary"/>
 <result pre="Clinical Trials Registry A prospective, randomized, open-label, controlled trial for" exact="chloroquine" post="and hydroxychloroquine in patients with severe novel coronavirus pneumonia"/>
 <result pre="Registry A prospective, randomized, open-label, controlled trial for chloroquine and" exact="hydroxychloroquine" post="in patients with severe novel coronavirus pneumonia (COVID-19) ChiCTR2000029992"/>
 <result pre="Chinese Clinical Trials Registry Evaluation the efficacy and safety of" exact="hydroxychloroquine" post="sulfate in comparison with phosphate chloroquine in mild and"/>
 <result pre="efficacy and safety of hydroxychloroquine sulfate in comparison with phosphate" exact="chloroquine" post="in mild and common patients with novel coronavirus pneumonia"/>
 <result pre="Chinese Clinical Trials Registry Evaluation the efficacy and safety of" exact="hydroxychloroquine" post="sulfate in comparison with phosphate chloroquine in severe patients"/>
 <result pre="efficacy and safety of hydroxychloroquine sulfate in comparison with phosphate" exact="chloroquine" post="in severe patients with novel coronavirus pneumonia (COVID-19): a"/>
 <result pre="open-label, controlled clinical study to evaluate the preventive effect of" exact="hydroxychloroquine" post="on close contacts after exposure to the novel coronavirus"/>
 <result pre="Trials Registry A multicenter, single-blind, randomized controlled clinical trial for" exact="chloroquine" post="phosphate in the treatment of novel coronavirus pneumonia (COVID-19)"/>
 <result pre="Registry A randomized controlled trial for favipiravir tablets combine with" exact="chloroquine" post="phosphate in the treatment of novel coronavirus pneumonia (COVID-19)"/>
 <result pre="(COVID-19) ChiCTR2000030987 Chinese Clinical Trials Registry Randomized controlled trial for" exact="chloroquine" post="phosphate in the treatment of novel coronavirus pneumonia (COVID-19)"/>
 <result pre="pneumonia (COVID-19) ChiCTR2000030718 Chinese Clinical Trials Registry Clinical study of" exact="chloroquine" post="phosphate in the treatment of severe novel coronavirus pneumonia"/>
 <result pre="Chinese Clinical Trials Registry Single arm study for exploration of" exact="chloroquine" post="phosphate aerosol inhalation in the treatment of novel coronavirus"/>
 <result pre="Clinical Trials Registry A single-blind, randomized, controlled clinical trial for" exact="chloroquine" post="phosphate in the treatment of novel coronavirus pneumonia 2019"/>
 <result pre="ChiCTR2000029939 Chinese Clinical Trials Registry A single-arm clinical trial for" exact="chloroquine" post="phosphate in the treatment of novel coronavirus pneumonia 2019"/>
 <result pre="pneumonia 2019 (COVID-19) ChiCTR2000029935 Chinese Clinical Trials Registry Efficacy of" exact="chloroquine" post="and lopinavir/ritonavir in mild/general novel coronavirus (CoVID-19) infections: a"/>
 <result pre="Registry A prospective, open-label, multiple-center study for the efficacy of" exact="chloroquine" post="phosphate in patients with novel coronavirus pneumonia (COVID-19) ChiCTR2000029609"/>
 <result pre="ChiCTR2000029609 Chinese Clinical Trials Registry Study for the efficacy of" exact="chloroquine" post="in patients with novel coronavirus pneumonia (COVID-19) ChiCTR2000029542 Chinese"/>
 <result pre="mg/d to 800 mg/d and comparators included placebo [17,20] or" exact="zidovudine" post="[18]. Two RCTs reported a significant decrease in viral"/>
 <result pre="used HCQ 400 mg/d alone [23] or in combination with" exact="hydroxyurea" post="plus didanosine [24]. There was a modest reduction in"/>
 <result pre="400 mg/d alone [23] or in combination with hydroxyurea plus" exact="didanosine" post="[24]. There was a modest reduction in viral load"/>
 <result pre="70 patients [21]. The comparators were either placebo [21,22] or" exact="zidovudine" post="plus didanosine (paediatric trial) [19]. Both adult trials enrolled"/>
 <result pre="[21]. The comparators were either placebo [21,22] or zidovudine plus" exact="didanosine" post="(paediatric trial) [19]. Both adult trials enrolled patients with"/>
 <result pre="400 mg/d for 12Â weeks added to interferon (IFN) and" exact="ribavirin" post="therapy, while the control group received IFN and ribavirin"/>
 <result pre="and ribavirin therapy, while the control group received IFN and" exact="ribavirin" post="only. HCQ was well tolerated and a significantly higher"/>
 <result pre="versus placebo in patients who had already failed IFN and" exact="ribavirin" post="therapy, and noted a significant drop in viral RNA"/>
 <result pre="therapy (p 0.04), but this effect was transient. IFN and" exact="ribavirin" post="therapy for HCV is largely outdated nowadays as highly"/>
 <result pre="approximately 14Â years) between test and control groups. Administration of" exact="azithromycin" post="to six subjects who also received HCQ does not"/>
 <result pre="achieving negative viraemia by day 14 compared to treatment with" exact="lopinavir" post="and ritonavir [40]. The authors report faster radiological improvement"/>
 <result pre="viraemia by day 14 compared to treatment with lopinavir and" exact="ritonavir" post="[40]. The authors report faster radiological improvement and reduced"/>
 <result pre="strategies against SARS coronavirus infectionsExpert Rev Anti-Infect Ther4200629130216597209 5RolainJ.M.ColsonP.RaoultD.Recycling of" exact="chloroquine" post="and its hydroxyl analogue to face bacterial, fungal and"/>
 <result pre="infections in the 21st centuryInt J Antimicrob Ag302007297308 6SavarinoA.BoelaertJ.R.CassoneA.MajoriG.CaudaR.Effects of" exact="chloroquine" post="on viral infections: an old drug against today's diseases?Lancet"/>
 <result pre="Zika virus NS2B-NS3 proteaseACS Omega32018181321814130613818 10ShiryaevS.A.MesciP.PintoA.FernandesI.SheetsN.ShrestaS.Repurposing of the anti-malaria drug" exact="chloroquine" post="for Zika virus treatment and prophylaxisSci Rep72017 11AkpovwaH.Chloroquine could"/>
 <result pre="patients with human immunodeficiency virus type 1Clin Ther1719956226368565026 18SperberK.ChiangG.ChenH.RossW.ChusidE.GoncharM.Comparison of" exact="hydroxychloroquine" post="with zidovudine in asymptomatic patients infected with human immunodeficiency"/>
 <result pre="human immunodeficiency virus type 1Clin Ther1719956226368565026 18SperberK.ChiangG.ChenH.RossW.ChusidE.GoncharM.Comparison of hydroxychloroquine with" exact="zidovudine" post="in asymptomatic patients infected with human immunodeficiency virus type"/>
 <result pre="with human immunodeficiency virus type 1Clin Ther1919979139239385480 19EngchanilC.KosalaraksaP.LumbiganonP.LulitanondV.PongjunyakulP.ThuennadeeR.Therapeutic potential of" exact="chloroquine" post="added to zidovudine plus didanosine for HIV-1 infected childrenJÂ"/>
 <result pre="virus type 1Clin Ther1919979139239385480 19EngchanilC.KosalaraksaP.LumbiganonP.LulitanondV.PongjunyakulP.ThuennadeeR.Therapeutic potential of chloroquine added to" exact="zidovudine" post="plus didanosine for HIV-1 infected childrenJÂ Med Assoc Thai8920061229123617048434"/>
 <result pre="1Clin Ther1919979139239385480 19EngchanilC.KosalaraksaP.LumbiganonP.LulitanondV.PongjunyakulP.ThuennadeeR.Therapeutic potential of chloroquine added to zidovudine plus" exact="didanosine" post="for HIV-1 infected childrenJÂ Med Assoc Thai8920061229123617048434 20PatonN.I.GoodallR.L.DunnD.T.FranzenS.Collaco-MoraesY.GazzardB.G.Effects of"/>
 <result pre="didanosine for HIV-1 infected childrenJÂ Med Assoc Thai8920061229123617048434 20PatonN.I.GoodallR.L.DunnD.T.FranzenS.Collaco-MoraesY.GazzardB.G.Effects of" exact="hydroxychloroquine" post="on immune activation and disease progression among HIV-infected patients"/>
 <result pre="receiving antiretroviral therapy: a randomized controlled trialJAMA308201235336122820788 21JacobsonJ.M.BosingerS.E.KangM.Belaunzaran-ZamudioP.MatiningR.M.WilsonC.C.The effect of" exact="chloroquine" post="on immune activation and interferon signatures associated with HIV-1AIDS"/>
 <result pre="with HIV-1AIDS Res Hum Retroviruses32201663664726935044 22MurrayS.M.DownC.M.BoulwareD.R.StaufferW.M.CavertW.P.SchackerT.W.Reduction of immune activation with" exact="chloroquine" post="therapy during chronic HIV infectionJÂ Virol842010120821208620844049 23PiconiS.ParisottoS.RizzardiniG.PasseriniS.TerziR.ArgenteriB.Hydroxychloroquine drastically reduces"/>
 <result pre="activation in HIV-infected, antiretroviral therapy-treated immunologic nonrespondersBlood11820113263327221576701 24PatonN.I.AboulhabJ.KarimF.Hydroxychloroquine, hydroxycarbamide, and" exact="didanosine" post="as economic treatment for HIV-1Lancet35920021667166812020529 25PeymaniP.GhavamiS.YeganehB.TabriziR.SabourS.GeramizadehB.Effect of chloroquine on"/>
 <result pre="hydroxycarbamide, and didanosine as economic treatment for HIV-1Lancet35920021667166812020529 25PeymaniP.GhavamiS.YeganehB.TabriziR.SabourS.GeramizadehB.Effect of" exact="chloroquine" post="on some clinical and biochemical parameters in non-response chronic"/>
 <result pre="pilot clinical trialActa Biomed8720164653 26PeymaniP.YeganehB.SabourS.GeramizadehB.FattahiM.R.KeyvaniH.New use of an old drug:" exact="chloroquine" post="reduces viral and ALT levels in HCV non-responders (a"/>
 <result pre="Pharmacol94201661361926998724 27HelalG.K.GadM.A.Abd-EllahM.F.EidM.S.Hydroxychloroquine augments early virological response to pegylated interferon plus" exact="ribavirin" post="in genotype-4 chronic hepatitis C patientsJÂ Med Virol8820162170217827183377 28TricouV.MinhN.N.VanT.P.LeeS.J.FarrarJ.WillsB.AÂ"/>
 <result pre="hepatitis C patientsJÂ Med Virol8820162170217827183377 28TricouV.MinhN.N.VanT.P.LeeS.J.FarrarJ.WillsB.AÂ randomized controlled trial of" exact="chloroquine" post="for the treatment of dengue in Vietnamese adultsPLoS Negl"/>
 <result pre="symptomsMem Inst Oswaldo Cruz108201359659923903975 30De LamballerieX.BoissonV.ReynierJ.C.EnaultS.CharrelR.N.FlahaultA.On chikungunya acute infection and" exact="chloroquine" post="treatmentVector Borne Zoonotic Dis8200883783918620511 31de LamballerieX.NinoveL.CharrelR.N.Antiviral treatment of chikungunya"/>
 <result pre="of chikungunya virus infectionInfect Disord Drug Targets9200910110419275698 32RoquesP.ThibervilleS.D.Dupuis-MaguiragaL.LumF.M.LabadieK.MartinonF.Paradoxical effect of" exact="chloroquine" post="treatment in enhancing chikungunya virus infectionViruses102018 33RavindranV.AliasG.Efficacy of combination"/>
 <result pre="enhancing chikungunya virus infectionViruses102018 33RavindranV.AliasG.Efficacy of combination DMARD therapy vs." exact="hydroxychloroquine" post="monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized"/>
 <result pre="technology of Guangdong Province health commission of Guangdong Province for" exact="chloroquine" post="in the treatment of novel coronavirus pneumoniaExpert Consensus Chloroquine"/>
 <result pre="for chloroquine in the treatment of novel coronavirus pneumoniaExpert Consensus" exact="Chloroquine" post="Phosphate Treat Novel Coronavirus Pneumonia432020185188 35GautretP.LagierJ.-C.ParolaP.HoangV.T.MeddebL.MailheM.Hydroxychloroquine and azithromycin as"/>
 <result pre="pneumoniaExpert Consensus Chloroquine Phosphate Treat Novel Coronavirus Pneumonia432020185188 35GautretP.LagierJ.-C.ParolaP.HoangV.T.MeddebL.MailheM.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
 <result pre="clinical trialInt J Antimicrob Agents202010594932205204 36Chen JunL.D.LiL.PingL.QingnianX.LuX.YunL.AÂ pilot study of" exact="hydroxychloroquine" post="in treatment of patients with common coronavirus disease-19 (COVID-19)JÂ"/>
 <result pre="patients with COVID-19: an open-label, randomized, controlled trialmedRxiv2020202004.10.20060558 38ChenZ.HuJ.ZhangZ.JiangS.HanS.YanD.Efficacy of" exact="hydroxychloroquine" post="in patients with COVID-19: results of a randomized clinical"/>
 <result pre="with COVID-19: results of a randomized clinical trialmedRxiv2020202003.22.20040758 39MagagnoliJ.NarendranS.PereiraF.CummingsT.HardinJ.W.SuttonS.S.Outcomes of" exact="hydroxychloroquine" post="usage in United States veterans hospitalized with Covid-19medRxiv2020202004.16.20065920 40HuangM.TangT.PangP.LiM.MaR.LuJ.Treating"/>
 <result pre="Mol Cell Biol2020 41BorbaM.G.S.ValF.F.A.SampaioV.S.AlexandreM.A.A.MeloG.C.BritoM.Effect of high vs low doses of" exact="chloroquine" post="diphosphate as adjunctive therapy for patients hospitalized with severe"/>
</results>
